Quality of biomarker defined subgroups in <scp>FDA</scp> approvals of <scp>PD</scp> ‐1/ <scp>PD‐L1</scp> inhibitors 2014 to 2020-Reference-Cited by-同舟云学术

Quality of biomarker defined subgroups in FDA approvals of PD ‐1/ PD‐L1 inhibitors 2014 to 2020

Published:2022-02-26 Issue:11 Volume:150 Page:1905-1910
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Kim Myung S.¹^ORCID,Xu Alexander²,Haslam Alyson³,Prasad Vinay³

Affiliation:

1. Division of Hematology and Medical Oncology, Knight Cancer Institute Oregon Health and Science University Portland Oregon USA

2. Sidney Kimmel Medical College Thomas Jefferson University Philadelphia Pennsylvania USA

3. Department of Epidemiology and Biostatistics University of California, San Francisco San Francisco California USA

Funder

Arnold Ventures

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33968

Reference22 articles.

1. Keytruda.Package insert. Merck & Co;2015.

2. Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression

3. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

4. SagonowskyE.The top 20 drugs by worldwide sales in 2020. Fierce Pharma website;2021.https://www.fiercepharma.com/special-report/top-20-drugs-by-2020-sales. Accessed August 17 2021.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study on the inflammatory microenvironment of Epstein‒Barr virus-infected Hodgkin's lymphoma;2024-06-18

2. Current state and challenges of emerging biomarkers for immunotherapy in hepatocellular carcinoma (Review);Experimental and Therapeutic Medicine;2023-11-03

3. Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics;mAbs;2023-03-30

4. Biomarker discovery and application—An opportunity to resolve the challenge of liver cancer diagnosis and treatment;Pharmacological Research;2023-03